Therapeutic Options in Refractory Diabetic Macular Oedema
Drugs (New York, N.Y.), 2017-04, Vol.77 (5), p.481-492 [Peer Reviewed Journal]Springer International Publishing Switzerland 2017 ;Copyright Springer Science & Business Media Apr 2017 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-017-0704-6 ;PMID: 28197794
Full text available